Skip to content
Search

Latest Stories

Pharmacy First needs an online booking system, just like COVID and Flu services

The current Pharmacy First model is overly reliant on referrals from GPs, says Waheedat Owodeyi.

Pharmacy First struggles: "I've barely completed 10 cases in a year," says pharmacist

Waheedat Owodeyi, owner and superintendent pharmacist at Pharmacyexprezz

A growing number of community pharmacies are closing permanently, mainly due to chronic underfunding and inadequate reimbursement.

Waheedat Owodeyi, owner and superintendent pharmacist at Pharmacyexprezz, said that financial pressures are not exclusive to traditional brick-and-mortar pharmacies—online pharmacies face the same struggles.


Speaking to Pharmacy Business, Waheedat described the current payment structure as "outdated," noting that it has remained unchanged despite advancements in digital systems.

“The way the NHS pays is complicated—you provide a service in January, but you don’t get paid until April,” Waheedat explained.

Adding to the complexity, payments are split into different components. “You receive a small amount at the start of the month—maybe just 10% of what you're owed—then another, unpredictable sum on the 10th. It feels like guesswork,” she said.

“But we have to pay the suppliers at the beginning of every month, which leaves us in debt for those two weeks.

“People say, ‘It’s always been done this way,’ but what may have worked in the past simply doesn’t work anymore—especially now, when there’s hardly any profit left,” Waheedat added.

Another major concern is unsustainable reimbursement rates.

“The government often reimburses less than the actual cost of medicines. For example, they might reimburse £1.50 for a product that costs £2, meaning we’re losing money on every sale.”

“In some cases, losses can be £10–£20 per box, making it impossible to stay profitable, yet the government still expects you to provide medication to patients,” Waheedat noted.

This financial strain has already led to mass closures because a business can’t run on constant losses, she said, adding that “unless negotiations bring real change, this crisis will continue.”

Beyond dispensing, pharmacies provide valuable services but are not adequately reimbursed.

“The government doesn't want to pay for prescriptions because they think that process can be automated—but you still need a human being,” Waheedat noted.

“If dispensing fees are being reduced and we're expected to focus on services, those services must be designed for efficient delivery,” she said, emphasising that the current Pharmacy First model is unsustainable.

Pharmacy First challenges

Waheedat feels that the current Pharmacy First model is difficult to operate efficiently as it creates dependency on others.

She stressed that an efficient online booking platform, similar to those used for COVID and flu vaccinations, is essential for Pharmacy First to reach its full potential.

“I’ve barely completed 10 cases in a year because the service relies on GPs referring patients or individuals seeking us out.”

She proposes a system where patients can directly book Pharmacy First services.

“This would boost patient engagement, reduce GP workload, improve service efficiency, and ensure help pharmacies meet government-imposed targets,” she said.

“The technology is there for them to be able to do it. It's just about them putting everything together to make sure that all these things can be done efficiently,” Waheedat added.

Currently, pharmacies must complete a minimum of 20 consultations monthly—to receive £1,000 at the end of the year.

“Some advance payments were provided, but because I didn’t meet the target, they deducted around £2,000 from me,” Waheedat revealed.

“The issue isn’t that I’m unwilling or unprepared; it’s that I simply don’t have enough patients coming in for the service.

“In contrast, I’ve administered over 12,000–13,000 COVID vaccinations since I started the service in 2021 or 2022, because the system enables patients to find and book the service efficiently.

“The problem with Pharmacy First is that while they’ve introduced the service, they’ve also placed restrictions on it,” she added.

Pharmacies have the potential to take on even more services, but structural reforms are necessary.

Waheedat said: “Negotiations should not only focus on adding more services but also on creating an accessible and functional platform where the patients can choose where they want to go and what service they want to get.

“Instead of penalizing pharmacies for not reaching targets, there should be financial incentives that reward performance—more services provided should mean more funding, not less.”

From March, pharmacists will be expected to provide Pharmacy First, blood pressure checks, contraception services, and more. While pharmacists are willing and ready, the system remains overly reliant on referrals from GPs.

A centralised NHS platform allowing patients to book directly at their preferred pharmacy would be a game-changer, according to Waheedat.

In this video, Waheedat discusses the difficulties in delivering the service...

- YouTubeyoutu.be

The future of pharmacy

Looking ahead, Waheedat envisions a more clinical and accessible pharmacy model where patients receive an expanded range of services.

“Private services hold immense potential—pharmacies will operate like minor ailments clinics,” she predicted.

On the NHS side, she sees inevitable integration.

“Whether now or in a few years, the government will recognise the accessibility and greater potential of pharmacies.

“Pharmacy will play a greater role in screenings, diagnostics, and preventative healthcare, reducing pressure on GPs and A&E.

"Right now, staying afloat is a challenge, but with the necessary support from the NHS, the future looks bright,” she concluded.

More For You

How community pharmacies can safely and profitably deliver high-quality NHS and private services

L-R: Baba Akomolafe, Rachna Chhatralia, Patricia Tigenoah-Ojo, and Raj Matharu

How community pharmacies are optimising services for a sustainable future

“Community pharmacy has come to a point where we have to change ourselves,” said Raj Matharu, CEO at Community Pharmacy South East London, and Superintendent Pharmacist of Westchem Pharmacy, as he opened a panel discussion at the recent Pharmacy Business Conference.

The 'Optimising Service Opportunities' session centred on how community pharmacies can safely and profitably deliver high-quality NHS and private services, while ensuring an excellent patient experience.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Janet Morrison discusses pharmacy funding strategy at 2025 conference

Health Secretary Wes Streeting outlines government support for community pharmacy

CPE calls new funding deal a ‘reluctant yes’

Community Pharmacy England (CPE) was “reluctant” to accept the new pharmacy funding deal due to the significant funding gap, said the organisation’s chief executive Janet Morrison, while recognising the settlement as the first step towards stabilising the sector.

Addressing the 2025 Pharmacy Business Conference on Sunday at London Hilton Wembley, Janet shared insights into the behind-the-scenes work that led to the agreement.

Keep ReadingShow less